ERLINDA CAPILI-ROSENKRANZ: Open Payments
NPI 1265494173 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 26 payments from 8 companies in 2025. Trend: 2023 $469 · 2024 $669 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $241 |
| Novo Nordisk Inc | 8 | $179 |
| Tandem Diabetes Care, Inc. | 2 | $55 |
| Ascendis Pharma Endocrinology Inc | 2 | $44 |
| Amgen Inc. | 2 | $33 |
| Insulet Corporation | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $23 |
| BETA BIONICS, INC. | 1 | $12 |
Products named: JARDIANCE, Ozempic, Rybelsus, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, EVENITY, OMNIPOD, TWIIST.
Industry payments across FL — which companies pay providers there.
